Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans
Bas B. Oude Munnink, Reina S. Sikkema, David F. Nieuwenhuijse, et al.
Science (2020) Vol. 371, Iss. 6525, pp. 172-177
Open Access | Times Cited: 1080

Showing 1-25 of 1080 citing articles:

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. García-Beltrán, Evan C. Lam, Kerri St. Denis, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2372-2383.e9
Open Access | Times Cited: 1429
Infectious disease in an era of global change
Rachel E. Baker, Ayesha S. Mahmud, Ian F. Miller, et al.
Nature Reviews Microbiology (2021) Vol. 20, Iss. 4, pp. 193-205
Open Access | Times Cited: 1167
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 664-670
Open Access | Times Cited: 1106
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 477-488.e4
Open Access | Times Cited: 809
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
Tyler N. Starr, Allison J. Greaney, Amin Addetia, et al.
Science (2021) Vol. 371, Iss. 6531, pp. 850-854
Open Access | Times Cited: 793
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas, Timothée Bruel, Ludivine Grzelak, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 917-924
Closed Access | Times Cited: 732
The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 724
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
Thomas P. Peacock, Daniel H. Goldhill, Jie Zhou, et al.
Nature Microbiology (2021) Vol. 6, Iss. 7, pp. 899-909
Open Access | Times Cited: 703
Genetic Variants of SARS-CoV-2—What Do They Mean?
Adam S. Lauring, Emma B. Hodcroft
JAMA (2021) Vol. 325, Iss. 6, pp. 529-529
Open Access | Times Cited: 624
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Emma C. Thomson, Laura E. Rosen, James G. Shepherd, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1171-1187.e20
Open Access | Times Cited: 623
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 519
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.
Cell (2021) Vol. 184, Iss. 8, pp. 2201-2211.e7
Open Access | Times Cited: 513
The origins of SARS-CoV-2: A critical review
Edward C. Holmes, Stephen A. Goldstein, Angela L. Rasmussen, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4848-4856
Open Access | Times Cited: 447
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.
Cell Reports (2022) Vol. 39, Iss. 7, pp. 110812-110812
Open Access | Times Cited: 396
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
S. Gobeil, Katarzyna Janowska, Shana McDowell, et al.
Science (2021) Vol. 373, Iss. 6555
Open Access | Times Cited: 395
After the pandemic: perspectives on the future trajectory of COVID-19
Amalio Telenti, Ann M. Arvin, Lawrence Corey, et al.
Nature (2021) Vol. 596, Iss. 7873, pp. 495-504
Open Access | Times Cited: 388
Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
Robert M. Cox, Josef D. Wolf, Richard K. Plemper
Nature Microbiology (2020) Vol. 6, Iss. 1, pp. 11-18
Open Access | Times Cited: 383
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2316-2331.e15
Open Access | Times Cited: 383
Tackling COVID-19 with neutralizing monoclonal antibodies
Davide Corti, Lisa A. Purcell, Gyorgy Snell, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3086-3108
Open Access | Times Cited: 369
SARS-CoV-2 infection in free-ranging white-tailed deer
Vanessa L. Hale, Patricia M. Dennis, Dillon S. McBride, et al.
Nature (2021) Vol. 602, Iss. 7897, pp. 481-486
Open Access | Times Cited: 354
Testing at scale during the COVID-19 pandemic
Tim R. Mercer, Marc Salit
Nature Reviews Genetics (2021) Vol. 22, Iss. 7, pp. 415-426
Open Access | Times Cited: 351
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
C. Garrett Rappazzo, Longping V. Tse, Chengzi I. Kaku, et al.
Science (2021) Vol. 371, Iss. 6531, pp. 823-829
Open Access | Times Cited: 348
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 297
Page 1 - Next Page

Scroll to top